Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis

被引：0
|
作者：
Inna Tabansky
Mark D. Messina
Catherine Bangeranye
Jeffrey Goldstein
Karen M. Blitz-Shabbir
Suly Machado
Venkatesh Jeganathan
Paul Wright
Souhel Najjar
Yonghao Cao
Warren Sands
Derin B. Keskin
Joel N. H. Stern
机构：
[1] The Rockefeller University,Department of Neurobiology and Behavior
[2] Hofstra North Shore-LIJ School of Medicine,Department of Neurology
[3] Hofstra North Shore-LIJ School of Medicine,Department of Science Education
[4] North Shore-LIJ Health System,Department of Autoimmunity, The Feinstein Institute for Medical Research
[5] Harvard University,School of Engineering and Applied Sciences
[6] University of Pittsburgh Medical Center,Department of Medicine
[7] Dana Farber-Harvard Cancer Institute,Department of Cancer Immunology and AIDS
来源：
Immunologic Research | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：640 / 640
相关论文
共 50 条
  • [21] Multiple sclerosis: pharmacogenomics and personalised drug treatment
    V. Annibali
    G. Ristori
    S. Cannoni
    S. Romano
    A. Visconti
    A. Ghazaryan
    L. Figà Talamanca
    M. Salvetti
    R. Mechelli
    Neurological Sciences, 2006, 27 : s347 - s349
  • [22] Regular review - Drug treatment of multiple sclerosis
    Polman, CH
    Uitdehaag, BMJ
    BRITISH MEDICAL JOURNAL, 2000, 321 (7259): : 490 - 494
  • [23] Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems
    Lin, Qianhan
    Li, Jiajia
    Abudousalamu, Zulimire
    Sun, Yating
    Xue, Mengyang
    Yao, Liangqing
    Chen, Mo
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 9351 - 9370
  • [24] Drug Insight: interferon treatment in multiple sclerosis
    Ruth Ann Marrie
    Richard A Rudick
    Nature Clinical Practice Neurology, 2006, 2 : 34 - 44
  • [25] TREATMENT OF MULTIPLE SCLEROSIS - A REVIEW OF DRUG THERAPY
    SCHUMACHER, GA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 143 (14): : 1241 - 1250
  • [26] Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
    Kang, Xuejia
    Jadhav, Sanika
    Annaji, Manjusha
    Huang, Chung-Hui
    Amin, Rajesh
    Shen, Jianzhong
    Ashby Jr, Charles R. R.
    Tiwari, Amit K. K.
    Babu, R. Jayachandra
    Chen, Pengyu
    PHARMACEUTICS, 2023, 15 (06)
  • [27] TREATMENT IND FOR MULTIPLE-SCLEROSIS DRUG
    NIGHTINGALE, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (08): : 974 - 974
  • [28] Multiple sclerosis: pharmacogenomics and personalised drug treatment
    Annibali, V.
    Ristori, G.
    Cannoni, S.
    Romano, S.
    Visconti, A.
    Ghazaryan, A.
    Talamanca, L. Figa
    Salvetti, M.
    Mechelli, R.
    NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 5) : S347 - S349
  • [29] Drug Insight: interferon treatment in multiple sclerosis
    Marrie, RA
    Rudick, RA
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (01): : 34 - 44
  • [30] Drug Delivery Systems for Diabetes Treatment
    Zaric, Bozidarka L.
    Obradovic, Milan
    Sudar-Milovanovic, EmMa
    Nedeljkovic, Jovan
    Lazic, Vesna
    Isenovic, Esma R.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (02) : 166 - 173
12345